10ye 1 10year yield highest since july the gop does move closer to tax reform what does that mean for investors . Ge is down sharply after a wider than expected Third Quarter miss slashing the full year guidance, revenue did meet estimates in the release John Flannery said this was a very challenging quarter. While a majority of our businesses had Solid Earnings performance this was offset by the decline in power performance in a difficult market. Stay tune for david aegs exclusive with flannery. Talking with squawk about this what are your thoughts is this below 22 yeah, i actually confronted jim immelt with many of these particular issues in my last interview with him and he was very much in denial these things would occur. I point that out because today is flannerys day. This is not a report card on flannery it is a statement that says heres all the things weve done wrong. I think they did very ill advised accounting in turbines and the key phrase here is that ge capital might have
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report)’s stock price rose 8.2% during mid-day trading on Monday . The company traded as high as $39.03 and last traded at $38.61. Approximately 174,823 shares were traded during trading, a decline of 71% from the average daily volume of 604,009 shares. The stock had previously closed at […]
Primecap Management Co. CA reduced its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 2.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,052,648 shares of the company’s stock after selling 214,773 shares during the period. […]
Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.